Literature DB >> 12621640

HLA typing does not predict REM sleep behaviour disorder and hallucinations in Parkinson's disease.

Marco Onofrj1, Anna Lisa Luciano, Diego Iacono, Astrid Thomas, Fabrizio Stocchi, Franco Papola, Domenico Adorno, Rocco Di Mascio.   

Abstract

HLA-DR2 haplotype and DQ1 DNA alleles, characterizing 90 to 100% of all narcoleptic patients, were found to be equally distributed in 20 Parkinson's disease (PD) patients with early hallucinations, rapid eye movement (REM) sleep-related behaviour disturbances (RBD), and sleep onset in REM (SOREM), and in 20 PD patients without hallucinations, despite 10 to 15 years of treatment, and no RBD or SOREM.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12621640     DOI： 10.1002/mds.10409

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


  9 in total

1.  Delayed blink reflex in dementia with Lewy bodies.

Authors:  Laura Bonanni; Francesca Anzellotti; Sara Varanese; Astrid Thomas; Lamberto Manzoli; Marco Onofrj
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-10       Impact factor: 10.154

Review 2.  REM sleep behavior disorder: Updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions.

Authors:  Bradley F Boeve
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

Review 3.  Hallucinations in Parkinson disease.

Authors:  Nico J Diederich; Gilles Fénelon; Glenn Stebbins; Christopher G Goetz
Journal:  Nat Rev Neurol       Date:  2009-06       Impact factor: 42.937

4.  Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.

Authors:  B F Boeve; M H Silber; T J Ferman; S C Lin; E E Benarroch; A M Schmeichel; J E Ahlskog; R J Caselli; S Jacobson; M Sabbagh; C Adler; B Woodruff; T G Beach; A Iranzo; E Gelpi; J Santamaria; E Tolosa; C Singer; D C Mash; C Luca; I Arnulf; C Duyckaerts; C H Schenck; M W Mahowald; Y Dauvilliers; N R Graff-Radford; Z K Wszolek; J E Parisi; B Dugger; M E Murray; D W Dickson
Journal:  Sleep Med       Date:  2013-03-07       Impact factor: 3.492

5.  Rapid eye movement sleep behavior disorder in adults younger than 50 years of age.

Authors:  Yo-El S Ju
Journal:  Sleep Med       Date:  2013-01-21       Impact factor: 3.492

Review 6.  Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

Authors:  Anna Chang; Susan H Fox
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

7.  Amantadine and cognitive flexibility: decision making in Parkinson's patients with severe pathological gambling and other impulse control disorders.

Authors:  Nicoletta Cera; Stefania Bifolchetti; Giovanni Martinotti; Francesco Gambi; Gianna Sepede; Marco Onofrj; Massimo Di Giannantonio; Astrid Thomas
Journal:  Neuropsychiatr Dis Treat       Date:  2014-06-17       Impact factor: 2.570

8.  Hypocretin (orexin) and melanin concentrating hormone loss and the symptoms of Parkinson's disease.

Authors:  Thomas C Thannickal; Yuan-Yang Lai; Jerome M Siegel
Journal:  Brain       Date:  2007-09-26       Impact factor: 13.501

9.  Hypocretin (orexin) cell loss in Parkinson's disease.

Authors:  Thomas C Thannickal; Yuan-Yang Lai; Jerome M Siegel
Journal:  Brain       Date:  2007-05-09       Impact factor: 13.501
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.